Compared to neurotypical individuals, standardized CBT-I for individuals with developmental disorders did not perform nearly as well.

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients ...

Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study.